Gladstone NOW: The Campaign Join Us on the Journey ✕
1411 - 1425 of 1449 Results Clear All
SAN FRANCISCO, CA—Alzheimer's disease is an extremely complicated disease. Several proteins seem to be involved in its cause and progression.
Alzheimer’s Disease Huang Lab
SAN FRANCISCO, CA—October 10, 2010—Scientists at the Gladstone Institute of Virology and Immunology (GIVI) have found that an enzyme associated with the storage of fat in the liver is required for the infectious activity of the hepatitis C virus (HCV).
SAN FRANCISCO, CA—Amyloid beta (Αβ) proteins, widely thought to cause Alzheimer's disease, block the transport of vital cargoes inside brain cells.
Alzheimer’s Disease Mucke Lab
SAN FRANCISCO, CA—Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) have found a new way to make beating heart cells from the body's own cells that could help regenerate damaged hearts.
Srivastava Lab Stem Cells/iPSCs
SAN FRANCISCO, CA—The Gladstone Institutes and the international pharmaceutical company H. Lundbeck A/S have announced a collaborative research agreement to study and identify therapeutic candidates for neurological diseases.
Akassoglou Lab Multiple Sclerosis
SAN FRANCISCO, CA—Scientists at the Gladstone Institute of Neurological Disease (GIND) and Stanford University have shown how key circuits in the brain control movement.
Parkinson’s Disease Kreitzer Lab Optogenetics
SAN FRANCISCO, CA—Shinya Yamanaka, MD, PhD, of the Gladstone Institute of Cardiovascular Disease (GICD) and Kyoto University, has won the 2010 Kyoto Prize for Advanced Technology.
SAN FRANCISCO, CA—June 15, 2010—The Institute for Systems Biology (ISB) of Seattle, WA, is collaborating with the Gladstone Institute of Neurological Disease (GIND) and its Taube-Koret Center for Huntington's Disease Research to use whole-genome sequencing to identify genes and novel drug targets
Huntington’s Disease
SAN FRANCISCO, CA—April 20, 2010—Deepak Srivastava, MD, director of the Gladstone Institute of Cardiovascular Disease and Professor of Pediatrics and Biochemistry at UCSF, has been elected to the American Academy of Arts and Sciences. Srivastava joins former Gladstone president Robert W.
SAN FRANCISCO—March 3, 2010—With obesity and obesity-related diseases epidemic in the developed world, a clear understanding of how metabolism is regulated is crucial. One of the key metabolic pathways involves the oxidation of fat.
SAN FRANCISCO, CA—February 18, 2010—Lennart Mucke, MD, Director of the Gladstone Institute of Neurological Disease (GIND), has been named a recipient of the American Academy of Neurology's prestigious Potamkin Prize.
Awards Alzheimer’s Disease
WASHINGTON—February 10, 2010—Robert W. Mahley, MD, PhD, president of The J. David Gladstone Institutes, will receive Research!America's 2010 Builders of Science Award.
Awards
SAN FRANCISCO, CA—February 8, 2010—The J. David Gladstone Institutes has announced the completion of its first fundraising campaign. The independent biomedical research organization, located at Mission Bay, said it had exceeded its goal of $35 million, despite tough economic times.
SAN FRANCISCO, CA—February 3, 2010—Although obesity is a risk factor for diabetes and coronary heart disease worldwide, only some obese individuals go on to develop these metabolic complications, while others are relatively protected.
SAN FRANCISCO, CA—Shinya Yamanaka, MD, PhD, of the Gladstone Institute of Cardiovascular Disease (GICD) was awarded the 2010 March of Dimes Prize in Developmental Biology.
